strontium [89sr ] chloride injection is used for palliative treatment of bone pain in patients with metastases from carcinomas of the prostatic gland and mammary gland. the most frequent indication for strontium[89sr ] chloride therapy are multiple spread metastases in patients formerly treated with conventional therapeutic methods in which no pain relief response was obtained.
nuclide data
t1/2 : 50.5d;
β- energy : 1.495mev
technical parameter
radionuclidic purity：＞99.9%
radioactive concentration：≥37mbq/ml
sr content：≤12.5mg/ml
al content：≤2μg/ ml
ph: 4.0～7.5
expiration: 30 days after production
specifications
111mbq ；148mbq；222mbq；296mbq